Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

A Human Pancreatic Islet Perturbation Atlas (HuPIPA) to decipher diabetes-relevant regulatory networks

Project description

Understanding type 2 diabetes pathophysiology for disease-modifying strategies

Type 2 diabetes (T2D) affects 1 in 10 adults worldwide and leads to 1.5 million deaths annually. Abnormal transcriptional programmes in pancreatic β-cells contribute to T2D, but our understanding of this remains incomplete. Current drug therapies primarily address hyperglycemia rather than the underlying causes of the disease. The MSCA-funded HuPIPA project aims to elucidate variations in β-cell transcriptional states. It will identify key cellular states by investigating regulatory responses to perturbations, offering insights into T2D pathophysiology and contributing to the development of disease-modifying strategies. The project will expand upon the Human Cell Atlas concept to establish the Human Pancreatic Islet Perturbation Atlas, characterising cell state dynamics through various perturbations.

Objective

Type 2 diabetes (or T2D) is a heterogeneous disease that affects nearly 1 in 10 adults worldwide, directly causing 1.5 million deaths each year. Human genetics and single cell genomic studies show that abnormal pancreatic β-cell transcriptional programs play a crucial role in type 2 diabetes. However, we lack an understanding of how this is translated into impaired β-cell function or mass.
Consequently, existing drug therapies for T2D aim to alleviate hyperglycaemia, but do not target causal mechanisms.

My overarching goal is to understand variation of β-cell transcriptional states.

I postulate that even if an infinite number of perturbations are conceivable, only a finite number of cell states exist. Identifying and characterizing major cellular states, by studying regulatory responses to perturbations could provide insights into T2D pathophysiology, and pave the way for disease-modifying strategies.

The concept of Human Cell Atlas currently depicts the cells landscape under one theoretical average condition, and does not represent the broad range of possible cell states that exist in different conditions. I'll be extending this concept towards the production of a Human Pancreatic Islet Perturbation Atlas (HuPIPA), which has the potential to be the first atlas characterizing cell states dynamics through multiple perturbations. I will harness this resource to unravel T2D mechanisms and to discover candidate therapeutic strategies.

To this end, I will design a large-scale single-cell multiomics experiment of human islets facing chemogenetic perturbations. I will
develop a novel statistical tool for the analysis of single-cell multiomics data under a broad range of conditions, and perform an
integrative analysis with T2D human genetic and single cell datasets.

This project, at the junction of statistics, genetics and computer science, has the potential to provide new knowledge for a better
understanding and treatment of T2D.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2023-PF-01

See all projects funded under this call

Coordinator

FUNDACIO CENTRE DE REGULACIO GENOMICA
Net EU contribution
€ 165 312,96
Address
CARRER DOCTOR AIGUADER 88
08003 Barcelona
Spain
Region
Este Cataluña Barcelona
Activity type
Research Organisations
Links
Total cost
No data